TIDMCLL

RNS Number : 2262F

Cello Group plc

21 May 2013

Cello Group plc ("Cello" or the "Company")

Director's dealing

The Company has been notified that on 21 May 2013 Mark Scott, the Chief Executive of the Company, purchased 13,700 ordinary shares of 10 pence each in the Company ("Ordinary Shares"). The purchase price was 54 pence per Ordinary Share. Following the purchase, Mr Scott is beneficially and non-beneficially interested in 899,619 Ordinary Shares, representing 1.1 per cent. of the current issued share capital of the Company.

21 May 2013

Enquiries:

    Cello Group                          020 7812 8460

Mark Bentley, Finance Director

    Cenkos Securities                    0207 397 8900

Bobbie Hilliam

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSUAVAROUAVUAR

Cello Health (LSE:CLL)
Historical Stock Chart
From Sep 2024 to Oct 2024 Click Here for more Cello Health Charts.
Cello Health (LSE:CLL)
Historical Stock Chart
From Oct 2023 to Oct 2024 Click Here for more Cello Health Charts.